FDA
-
-
-
-
-
-
-
Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
-
-
-
-
-
-
-
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
-
-
-
-
-
-
-
Helus Pharma adds Dr. Robert Langer and Dr. Stephen Brannan to advisory board
-
-
-
-
-
-
-
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
-
-
-
-
-
-
-
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
-
-
-
-
-
-
326,554 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

